http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a9232eea75b5c524b81b4085e019e0b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Gardner |
| name | Humphrey Gardner |
| given-name | Humphrey |
| organization-name | Department of Translational Medicine, Infection, AstraZeneca, Waltham, MA 02451; †Biogen Idec, Cambridge, MA 02142 2AstraZeneca, Waltham, Massachusetts. From the Department of Neurology, Medical School, University of Heidelberg, Heidelberg, Germany (S.H., P.K., S.W.); Division of Biostatistics, Scripps Research Institute, La Jolla, Calif (J.K.); and Biogen, Cambridge, Mass (H.G.) Authors' Affiliations: 1Department of Oncology, Odense University Hospital, Odense, Denmark; 2Institute of Clinical Research, University of Southern Denmark, Odense, Denmark; 3Department of Pathology, University Hospital of Copenhagen, Copenhagen, Denmark; 4Oncology Translational Laboratories, Novartis Institutes for Biomedical Research, Boston, Massachusetts; and 5Novartis Pharma AG, Basel, Switzerland From the Vall d'Hebron University Hospital, Barcelona; Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain; NN Petrov Research Institute of Oncology; and City Oncological Dispensary, St Petersburg, Russian Federation; Onc Centrum St Augustinus, Wilrijk, Belgium; Centre Rene Gauducheau, Nantes, France; Department of Special Gynecology, Medical University of Vienna/Austria; University Hospital, Salzburg, Austria; Istituto Nazionale Tumori, Milan, Italy; Novartis Pharma AG, Basel, Switzerland;... Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA Translational Medicine, Astrazeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA, humphrey.gardner@astrazeneca.com. Authors' Affiliations: 1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 2Medical Oncology, University of Louisville, Louisville, Kentucky; 3Novartis Oncology, East Hanover, New Jersey; and 4Melanoma Program, Division of Medical Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania Novartis Institutes for Biomedical Research, Cambridge, Massachusetts From the Division of Urology and Department of Pathology, Beth Israel Hospital, and Division of Urology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts The Scripps Research Institute Department of Cell Biology La Jolla California †Novartis Institutes for Biomedical Research, Cambridge, MA 02139; and Translational Science, IMED Infection, AstraZeneca, Waltham, Massachusetts, United States From the Department of Pathology (K.S., E.L., A.R., M.D., S.H.), Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands; and Biogen Idec (A.d.F., A.S., H.G., V.K.) and Alnylam Pharmaceuticals (A.d.F., A.S., V.K.), Cambridge, Mass. Evelo Biosciences Cambridge MA USA 2 Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA 1 Department of Cell Biology, The Scripps Research Institute, La Jolla, California USA 92037, USA Toni K. Choueiri, Dana-Farber Cancer Institute, Boston; Melanie M. Frigault, Edwin A. Clark, Amir A. Handzel, and Humphrey Gardner, AstraZeneca, Waltham, MA; Elizabeth Plimack, Fox Chase Cancer Center, Philadelphia, PA; Eric Jonasch, MD Anderson Cancer Center, Houston, TX; Sumanta Kumar Pal, City of Hope, Duarte, CA; Hendrik-Tobias Arkenau, Sarah Cannon Research Institute, University College London Cancer Institute; Thomas Powles, Barts Cancer Institute, London; Shethah Morgan, AstraZeneca, Cambridge,... Infection Innovative Medicines Unit, AstraZeneca R&D Boston, Waltham, Massachusetts, USA Translational Medicine, Early Clinical Development, AstraZeneca, Gatehouse Park, Waltham, MA, USA |
Incoming Links
Total number of triples: 88.